|
[1]VILSTRUP H,AMODIO P,BAJAJ J,et al.Hepatic encephalopathy in chronic liver disease:2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases[J].Hepatology,2014,60(2):715-735.
|
|
[2]LAURIDSEN MM,VILSTRUP H.Diagnosing covert hepatic encephalopathy:diagnosing covert hepatic encephalopathy[J].Clin Liver Dis,2015,5(3):71-74.
|
|
[3]WEISSENBORN K,ENNEN JC,SCHOMERUS H,et al.Neuropsychological characterization of hepatic encephalopathy[J].J Hepatol,2001,34(5):768-773.
|
|
[4]AMODIO P,CAMPAGNA F,OLIANAS S,et al.Detection of minimal hepatic encephalopathy:normalization and optimization of the Psychometric Hepatic Encephalopathy Score.Aneuropsychological and quantified EEG study[J].J Hepatol,2008,49(3):346-353.
|
|
[5] ROMERO-GMEZ M,CRDOBA J,JOVER R,et al.Value of the critical flicker frequency in patients with minimal hepatic encephalopathy[J].Hepatology,2007,45(4):879-885.
|
|
[6] GONG YX.Revision of wechsler adult intelligence scale[J].Acta Psychol Sin,1983,15(3):362-369.(in Chinese)龚耀先.韦氏成人智力量表的修订[J].心理学报,1983,15(3):362-369.
|
|
[7]YE RF,GONG YX.Neuropsychological tests in patients with liver cirrhosis[J].Chin Mental Health J,2001,15(4):254-259.(in Chinese)叶瑞繁,龚耀先.神经心理学测验与亚临床肝性脑病的检测[J].中国心理卫生杂志,2001,15(4):254-259.
|
|
[8]LIN Y,FAN YP,YU JJ,et al.Diagnostic value of the evoked potentials in liver cirrhotic patients with minimal hepatic encephalopathy[J].Chin J Dig,2010,30(7):444-447.(in Chinese)林言,范燕萍,余建军,等.诱发电位对肝硬化患者轻微肝性脑病的诊断价值[J].中华消化杂志,2010,30(7):444-447.
|
|
[9]KULLMANN F,HOLLERBACH S,LOCK G,et al.Brain electrical activity mapping of EEG for the diagnosis of subclinical hepatic encephalopathy in chronic liver disease[J].Eur J Gastroenterol Hepatol,2001,13(5):513-522.
|
|
[10] BERNTHAL P,HAYS A,TARTER RE,et al.Cerebral CT scan abnormalities in cholestatic and hepatocellular disease and their relationship to neuropsychologic test performance[J].Hepatology,1987,7(1):107-114.
|
|
[11]KRIEGER D,KRIEGER S,JANSEN O,et al.Manganese and chronic hepatic encephalopathy[J].Lancet,1995,346(8970):270-274.
|
|
[12]CHEN XR,SHEN TZ,TANG WJ,et al.Functional MRI---Ahot research topic in neuroimaging[J].Chin Comput Med Imag,2004,10(5):289-291.(in Chinese)陈星荣,沈天真,汤伟军,等.功能性磁共振成像---神经影像学的研究热点[J].中国医学计算机成像杂志,2004,10(5):289-291.
|
|
[13]GEISSLER A,LOCK G,FRND R,et al.Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging[J].Hepatology,1997,25(1):48-54.
|
|
[14]HASSAN EA,ABD EL-REHIM AS,SEIFELDEIN GS,et al.Minimal hepatic encephalopathy in patients with liver cirrhosis:magnetic resonance spectroscopic brain findings versus neuropsychological changes[J].Arab J Gastroenterol,2014,15(3-4):108-113.
|
|
[15] FURUYA S,NARUSE S,IDE M,et al.The clinical application of multi-voxel 1H-CSI(chemical shift imaging)in brain tumors[J].Nihon Igaku Hoshasen Gakkai Zasshi,1991,51(7):836-838.
|
|
[16]KANG JY.Influencing factors of MR diffusion-weighted signal[J].J Dalian Med Univ,2004,26(2):152.(in Chinese)康建蕴.影响磁共振弥散加权成像信号的因素[J].大连医科大学学报,2004,26(2):152.
|
|
[17]THOMALLA G,GLAUCHE V,KOCH MA,et al.Diffusion tensor imaging detects early Wallerian degeneration of the pyramidal tract after ischemic stroke[J].Neuroimage,2004,22(4):1767-1774.
|
|
[18] AKBAR N,LOBAUGH NJ,O'CONNOR P,et al.Diffusion tensor imaging abnormalities in cognitively impaired multiple sclerosis patients[J].Can J Neurol Sci,2010,37(5):608-614.
|
|
[19]KONG X,QI RF,LIANG X,et al.Study of voxel-based whole brain diffusion tensor imaging in cirrhotic patients[J].Radiol Pract,2014,29(1):16-20.(in Chinese)孔祥,戚荣丰,梁雪,等.肝硬化患者基于体素的全脑扩散张量成像研究[J].放射学实践,2014,29(1):16-20.
|
|
[20]HENKELMAN RM,STANISZ GJ,GRAHAM SJ.Magnetization transfer in MRI:a review[J].NMR Biomed,2001,14(2):57-64.
|
|
[21] ROVIRA A,GRIVE E,PEDRAZA S,et al.Magnetization transfer ratiovalues and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis[J].AJNR Am J Neuroradiol,2001,22(6):1137-1142.
|
|
[22]JING B,SHEN W,ZHANG LJ,et al.Quantitative analysis of brain changes of hepatic encephalopathy with magnetization transfer imaging[J].Chin J Med Imaging Technol,2009,25(4):581-584.(in Chinese)姜滨,沈文,张龙江,等.磁化传递成像定量研究肝硬化肝性脑病患者肝移植前后的脑改变[J].中国医学影像技术,2009,25(4):581-584.
|
|
[23]CORDOBA J,ALONSO J,ROVIRA A,et al.The development of low-grade cerebral edema in cirrhosis is supported by the evolution of 1H-magnetic resonance abnormalities after liver transplantation[J].JHepatol,2001,35(5):598-604.
|
|
[24]YAZGAN Y,NARIN Y,DEMIRTURK L,et al.Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy[J].J Gastroenterol Hepatol,2003,18(10):1162-1167.
|
|
[25] LOCKWOOD AH,MURPHY BW,DONNELLY KZ,et al.Positronemission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy[J].Hepatology,1993,18(5):1061-1068.
|
|
[26] TOWNSEND DW,CARNEY JP,YAP JT,et al.PET/CT today and tomorrow[J].J Nucl Med,2004,45(Suppl 1):4s-14s.
|
|
[27]NAKAGAWA Y,MATSUMURA K,IWASA M,et al.Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy[J].Ann Nucl Med,2004,18(2):123-129.
|
|
[28]YANG G,LI L,LIANG Q.Characteristics and clinical use of various functional imaging technologies[J].Inf Med Equip,2007,22(12):38-40.(in Chinese)杨刚,李林,良泉.不同功能成像技术的特性与临床应用[J].医疗设备信息,2007,22(12):38-40.
|
|
[29]ORTIZ M,JACAS C,CRDOBA J.Minimal hepatic encephalopathy:diagnosis clinical significance and recommendations[J].JHepatol,2005,42(Suppl 1):s45-s53.
|
|
[30]de RUI M,MONTAGNESE S,AMODIO P.Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy[J].Expert Rev Gastroenterol Hepatol,2016,10(4):443-450.
|
|
[31]SHARMA P,SHARMA BC,SARIN SK,et al.Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis[J].Hepatobiliary Pancreat Dis Int,2010,9(1):27-32.
|
|
[32]LIU DS,GAO W,YAN M,et al.The brainstem auditory evoked potentials in subclinical hepatic encephalopathy[J].Shangdong J Biomed Eng,2002,21(4):36-37.(in Chinese)刘德山,高伟,阎明,等.脑干听觉诱发电位检测对亚临床肝性脑病的诊断价值[J].山东生物医学工程,2002,21(4):36-37.
|
|
[33]LIU DS,CHAI Q,GAO W,et al.Study of visual and somatosensory evoked potentials in the patients with liver cirrhosis[J].J Biomed Eng Res,2003,22(3):33-35.(in Chinese)刘德山,柴青,高伟,等.肝硬化患者视觉和体感诱发电位的研究[J].生物医学工程研究,2003,22(3):33-35.
|
|
[34] KUGLER CF,LOTTERER E,PETTER J,et al.Visual event-related P300 potentials in early portosystemic encephalopathy[J].Gastroenterology,1992,103(1):302-310.
|
|
[35]NADIM MK,DURAND F,KELLUM JA,et al.Management of the critically ill patient with cirrhosis:a multidisciplinary perspective[J].J Hepatol,2016,64(3):717-735.
|
|
[36] WEISSENBORN K.Challenges in diagnosing hepatic encephalopathy[J].Neurochem Res,2015,40(2):265-273.
|
|
[37]SCHOMERUS H,HAMSTER W,BLUNCK H,et al.Latent portasystemic encephalopathy.I.Nature of cerebral functional defects and their effect on fitness to drive[J].Dig Dis Sci,1981,26(7):622-630.
|
|
[38]LALAMA MA,SALOUM Y.Nutrition,fluid and electrolytes in chronic liver disease[J].Clin Liver Dis,2016,7(1):18-20.
|
|
[39]MAHARSHI S,SHARMA BC,SACHDEVA S,et al.Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial[J].Clin Gastroenterol Hepatol,2016,14(3):454-460.
|
|
[40]WANG YM,YAN ZH.The new concepts on hepatic encephalopathy[J].J Clin Hepatol,2010,26(6):568-574.(in Chinese)王宇明,晏泽辉.肝性脑病诊断治疗新认识[J].临床肝胆病杂志,2010,26(6):568-574.
|
|
[41] BIANCHI GP,MARCHESINI G,FABBRI A,et al.Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy.A randomized cross-over comparison[J].J Intern Med,1993,233(5):385-392.
|
|
[42]NGUYEN DL,MORGAN T.Protein restriction in hepatic encephalopathy is appropriate for selected patients:a point of view[J].Hepatol Int,2014,8(2):447-451.
|
|
[43] BADEA MA,PRELIPCEAN CC,MIHAI C,et al.Current concepts in minimal hepatic encephalopathy[J].Rev Med Chir Soc Med Nat Iasi,2015,119(1):9-17.
|
|
[44]BAJAJ JS.Minimal hepatic encephalopathy matters in daily life[J].World J Gastroenterol,2008,14(23):3609-3615.
|
|
[45]PRASAD S,DHIMAN RK,DUSEJA A,et al.Lactulose improves cognitive functions and health-related quality of life cirrhosis who have minimal hepatic encephalopathy[J].Hepatology,2007,45(3):549-559.
|
|
[46]GENTILE S,GUARINO G,ROMANO M,et al.A randomized controlled trial of acarbose in hepatic encephalopathy[J].Clin Gastroenterol Hepatol,2005,3(2):184-191.
|
|
[47] SIDHU SS,GOYAL O,MISHRA BP,et al.Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy(the RIME trial)[J].Am J Gastroenterol,2011,106(2):307-316.
|
|
[48]GUPTA A,DHIMAN RK,KUMARI S,et al.Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy[J].J Hepatol,2010,53(5):849-855.
|
|
[49]SIRINGO S,VAIRA D,MENEGATTI M,et al.High prevalence of helicobacter pylori in liver cirrhosis:relationship with clinical and endoscopic features and the risk of peptic ulcer[J].Dig Dis Sci,1997,42(10):2024-2030.
|
|
[50]ABDEL-HADY H,ZAKI A,BADRA G,et al.Helicobacter pylori infection in hepatic encephalopathy:relationship to plasma endotoxins and blood ammonia[J].Hepatol Res,2007,37(12):1026-1033.
|
|
[51]MIQUEL J,BARCENA R,BOIXEDA D,et al.Role of Helicobacter pylori infection and its eradication in patients with subclinical hepatic encephalopathy[J].Eur J Gastroenterol Hepatol,2001,13(9):1067-1072.
|
|
[52]WU J.Role of Helicobacter pylori in pathogenesis of minimal hepatic encephalopathy and clinical impact after the treatment of HP[J].Chin J Nosocomiol,2013,23(15):3642-3644.(in Chinese)吴娟.幽门螺杆菌在轻微肝性脑病发病机制中的作用及HP根治治疗后临床影响[J].中华医院感染学杂志,2013,23(15):3642-3644.
|
|
[53]WANG LJ,CAI JT,CHEN T,et al.The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients[J].Chin J Intern Med,2006,45(8):654-657.(in Chinese)王良静,蔡建庭,陈涛,等.幽门螺杆菌感染对高氨血症和肝性脑病发病的影响[J].中华内科杂志,2006,45(8):654-657.
|
|
[54]WANG KJ,SONG HM.L-Ornithine-L-Aspartate for the treatment of cirrhotic patients with hepatic encephalopathy:a meta-analysis[J].Chin Gen Pract,2012,15(30):3451-3454.(in Chinese)王旷靖,宋汉明.L鸟氨酸L门冬氨酸治疗肝硬化肝性脑病的Meta分析[J].中国全科医学,2012,15(30):3451-3454.
|
|
[55]LI YY.Treatment of hepatic encephalopathy and minimal hepatic encephalopathy with L-ornitine-L-aspartate[J].J Clin Hepatol,2011,27(1):100-102.(in Chinese)李瑜元.门冬氨酸鸟氨酸治疗显性和轻微型肝性脑病[J].临床肝胆病杂志,2011,27(1):100-102.
|
|
[56] JIANG Q,JIANG XH,ZHENG MH,et al.L-Ornithine-L-aspartate in the management of hepatic encephalopathy:a meta-analysis[J].J Gastroenterol Hepatol,2009,24(1):9-14.
|
|
[57]Chinese Society of Gastroenterology and Chinese Society of Hepatology,Chinese Medical Association.Consensus on the diagnosis and treatment of hepatic encephalopathy in China(Chongqing,2013)[J].Chin J Hepatol,2013,21(9):641-651.(in Chinese)中华医学会消化病学分会,中华医学会肝病学分会.中国肝性脑病诊治共识意见(2013年,重庆)[J].中华肝脏病杂志,2013,21(9):641-651.
|
|
[58] TANG XL,HU L,SHENG RL.Efficacy of arginine in treatment of hepatic encephalopathy in patients with liver cirrhosis and severe hepatitis[J].J Chin Mod Med,2006,3(5):580-581.(in Chinese)汤习良,胡莉,盛瑞玲.精氨酸对肝硬化与重症型肝炎中肝性脑病的疗效观察[J].中华现代内科杂志,2006,3(5):580-581.
|
|
[59] LEMBERG A,FERNNDEZ MA.Hepatic encephalopathy,ammonia,glutamate,glutamine and oxidative stress[J].Ann Hepatol,2009,8(2):95-102.
|
|
[60]YAN M,ZHANG SZ,ZHAO XC,et al.An analysis of serum aminogram of subclinical hepatic encephalopathy60[J].Chin J Hepatol,1998,6(2):116.(in Chinese)〗阎明,张尚忠,赵宪村,等.亚临床型肝性脑病的血清氨基酸谱分析[J].中华肝脏病杂志,1998,6(2):116.
|
|
[61]MARCHESINI G,BIANCHI G,MERLI M,et al.Nutritional supplementation with branched-chain amino acids in advanced cirrhosis:a double-blind,randomized trial[J].Gastroenterology,2003,124(7):1792-1801.
|
|
[62] GLUUD LL,DAM G,LES I,et al.Branched-chain amino acids for people with hepatic encephalopathy[J].Cochrane Database Syst Rev,2015,9:CD001939.
|
|
[63] DAM G,KEIDING S,MUNK OL,et al.Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects[J].Am J Physiol Gastrointest Liver Physiol,2011,301(2):g269-g277.
|
|
[64]DAM G,OTT P,AAGAARD NK,et al.Branched-chain amino acids and muscle ammonia detoxification in cirrhosis[J].Metab Brain Dis,2013,28(2):217-220.
|
|
[65] LES I,DOVAL E,GARCIA-MARTINEZ R,et al.Effects of branched-chain aminoacids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy:a randomized study[J].Am J Gastroenterol,2011,106(6):1081-1088.
|
|
[66]HOLECEK M.Branched-chain amino acids and ammonia metabolism in liver disease:therapeutic implications[J].Nutrition,2013,29(10):1186-1191.
|
|
[67]WANG GD,SU QF,ZHANG HW.Efficacy of naloxone versus lactulose in treatment of minimal hepatic encephalopathy in patients with liver cirrhosis:a comparative analysis[J].China Prac Med,2012,7(34):123-124.(in Chinese)王国栋,苏钦峰,张红伟.纳洛酮乳果糖治疗肝硬化轻微肝性脑病对照分析[J].中国实用医药,2012,7(34):123-124.
|
|
[68]SEYAN AS,HUGHES RD,SHAWCROSS DL.Changing face of hepatic encephalopathy:role of inflammation and oxidative stress[J].World J Gastroenterology,2010,16(27):3347-3357.
|
|
[69]GLUUD LL,DAM G,BORRE M,et al.Lactulose,rifaximin or branched chain amino acids for hepatic encephalopathy:what is the evidence?[J].Metab Brain Dis,2013,28(2):221-225.
|
|
[70] SIMON-TALERO M,VENTURA M,CORDOBA J.Minimal hepatic encephalopathy[M].//Gines P,Forns X,Fernandez J,Crespo G,et al.Therapy in Liver Diseases,Barcelona:Elsevier Doyma.2013:151-157.
|
PDF下载 ( 1616 KB)
本文二维码
下载:
